午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Amyloid β-Protein (4-42)

Amyloid β-Protein (4-42) Struktur
157884-72-5
CAS-Nr.
157884-72-5
Englisch Name:
Amyloid β-Protein (4-42)
Synonyma:
Amyloid β-Protein (4-42);Amyloid β-Protein (4-42) ammonium salt;Amyloid β-Protein (4-42) ammonium salt/Aβ (4-42);Amyloid Bate-Protein (4-42) ammonium salt/A Bate (4-42)
CBNumber:
CB53379900
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Amyloid β-Protein (4-42) Eigenschaften

Sequenz
H-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-As

Sicherheit

Amyloid β-Protein (4-42) Chemische Eigenschaften,Einsatz,Produktion Methoden

Amyloid β-Protein (4-42) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Amyloid β-Protein (4-42) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 30)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 10985 58
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715
admin@nexconn.com China 10406 58
Hangzhou Go Top Peptide Biotech
0571-88211921
sales1@gotopbio.com CHINA 2609 58
Nanjing TGpeptide
+86-13347807150
support@tgpeptide.com China 3279 58
Changsha MOL Changes Biotechnology Co., Ltd.
+8619375158599
info@molchanges.com China 5220 58
Moxin Chemicals
+8617320513646
Anna@molcoo.com China 9887 58
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 12952 65
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303
Caroline@youngshechem.com China 4800 58
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919
Eric@peptidego.com China 7222 58
Nanjing TGpeptide Biotechnology Co.,Ltd. 18115476705
sales@tgpeptide.com China 3058 58

  • Amyloid β-Protein (4-42)
  • Amyloid β-Protein (4-42) ammonium salt/Aβ (4-42)
  • Amyloid β-Protein (4-42) ammonium salt
  • Amyloid Bate-Protein (4-42) ammonium salt/A Bate (4-42)
  • 157884-72-5
Copyright 2019 ? ChemicalBook. All rights reserved